Many patients with locally advanced breast cancer do not undergo recommended postmastectomy radiotherapy
the ONA take:
Patients with breast cancer who undergo a mastectomy should receive subsequent postmastectomy radiation therapy (PMRT), which is found to reduce the risk of breast cancer recurrence and improve survival in patients with locally advanced breast cancer with a pathological stage of N2 or N3.
However, only 65% of these patients are receiving the postsurgical radiation therapy, which is the standard of care. In this study, researchers from Louisiana State University (LSU) Health Sciences Center in Shreveport evaluated compliance with the treatment guidelines using the National Cancer Data Base (NCDB).
They reviewed 56,990 de-identified files from NCDB of women with N2 or N3 cancer to determine factors linked to receipt of PMRT.
Their review revealed that only three factors independently predicted a higher likelihood that patients would receive PMRT: receipt of chemotherapy, readmission to the hospital within the first month after mastectomy, and being alive 30 days after the surgery.
In addition, this study highlighted an important issue regarding implementing new research findings into clinical practice.
On average, the time from when a new intervention is recommended as evidence-based practice to full adoption in the clinical setting is 9 years.
Only 65% of patients with advanced breast cancer are receiving the postsurgical radiation therapy.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|